Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges

• Main Authors: Lu Gan (Author), Demin Liu (Author), Yanan Ma (Author), Xuening Chen (Author), Aihui Dai (Author), Sihan Zhao (Author), Xiaoxue Jin (Author), Guoqiang Gu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Immune checkpoint inhibitors (ICIs) are the most notable breakthrough in tumor treatment. ICIs has been widely used in tumor patients, but its wide range of immune-related adverse events (irAEs) should not be ignored. irAEs can be involved in any organ system, including immune-related cardiotoxicity...